Shilanski & Associates’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Shilanski & Associates's MRK Position: Q3 2025 in Review
Shilanski & Associates opened a new position in Merck (MRK) in Q3 2025: 2,563 shares worth $215K. The stake represents 0.06% of the portfolio and ranks #104 among its holdings. This is a return to the name: Shilanski & Associates previously reported a position in MRK as recently as Q1 2025.
Shilanski & Associates first reported a position in MRK in Q2 2019 and has held it in 17 quarters since. The position peaked at $503K in Q4 2019. 3,316 funds tracked by Wall St. Rank hold MRK as of Q3 2025.
- Shilanski & Associates held 2,563 shares of Merck worth $215K as of Q3 2025.
- Merck was a new Shilanski & Associates position in Q3 2025.
- Merck made up 0.06% of Shilanski & Associates's portfolio in Q3 2025, its #104 holding.
- Shilanski & Associates first reported a position in Merck in Q2 2019 and has held it in 17 quarters since.
- Shilanski & Associates's Merck position peaked at $503K in Q4 2019.
- 3,316 funds tracked by Wall St. Rank held Merck as of Q3 2025.
Based on Shilanski & Associates's 13F filing for Q3 2025, filed 20 Oct 2025.